Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Development-stage index

Not applicablePeptide Trials.

Explore every Not applicable peptide study in the local registry snapshot. Compare recruitment, sponsors, therapeutic areas, enrollment, results, publications and study geography.

Studies
369
Recruiting
72
Completed
156
Results posted
31
Countries
43
Avg enrollment
507

Velocity

Not applicable trials by start year

Study start year · indexed snapshot

60453015019971997: 1 trials1998: 0 trials1999: 0 trials2000: 1 trials2001: 0 trials2002: 1 trials20032003: 3 trials2004: 2 trials2005: 3 trials2006: 5 trials2007: 6 trials2008: 4 trials20092009: 10 trials2010: 8 trials2011: 4 trials2012: 8 trials2013: 4 trials2014: 7 trials20152015: 13 trials2016: 13 trials2017: 15 trials2018: 19 trials2019: 17 trials2020: 13 trials20212021: 21 trials2022: 30 trials2023: 25 trials2024: 40 trials2025: 33 trials2026: 60 trials20272027: 3 trials

Development

Trials by phase

Early Phase 10
Phase 10
Phase 20
Phase 30
Phase 40

Industry

Leading sponsors

Adenocyte, LLC1
Alimetry1
Bristol-Myers Squibb1
Diabetes Care Center1
HyGIeaCare, Inc.1
Phenomix Sciences1
Sofwave Medical LTD1

Therapeutic areas

Condition groups

Weight loss31
Type 2 diabetes19
Brain health13
Longevity10
Inflammation8
Pain8
Muscle growth1

Compound leaders

Most represented peptides.

01Carbetocin3302Oxytocin3303Terlipressin3004Cetrorelix2305Calcitonin2106Pramlintide2007Vasopressin1808Desmopressin1709Nesiritide1710Ganirelix1511Exenatide1312Semaglutide13

Study explorer

Search this collection.

369 matching studies